July 31, 2010
HomeReportsBlogContact UsLegal DisclaimerSuggestions
 

Arthrocare (NASDAQ:ARTC) is Living in Denial

Posted in Citron Reports by CitronResearch on the April 18th, 2008

 stock ticker: ARTC
“Denial is a common tactic that substitutes deliberate ignorance for thoughtful planning.”
CHARLES TREMPER

As Arthrocare (NASDAQ:ARTC) prepares for its earnings report and conference call on Monday, investors should be preparing as well:  preparing to hold management accountable to stop denying the important issues that threaten the company, as reflected in current legal proceedings that seek to unmask their business model.  With an upside down balance sheet in an industry that has become a hotbed for regulation from the Department of Justice, it appears to Citron that the problems at Arthrocare have just begun.

(more…)

Citron Exposes the 3-Way Scheme Behind Emcore

Posted in Citron Reports by CitronResearch on the April 14th, 2008

Citron Examines Valence Technology (NASDAQ:VLNC)

Posted in Citron Reports by CitronResearch on the April 9th, 2008

Basin Water - Down the Drain with Self-Dealing, Insider Dumping, Corporate Defection, and Mysterious Customers

Posted in Citron Reports by CitronResearch on the April 7th, 2008